Suven Life Sciences Ltd. Financials: Quarterly Results
Revenue
2.69
Cr.
PAT
-43.94
Cr.
EBITDA
-43.94
Cr.
Suven Life Sciences Ltd. Q4FY25 Financial Metrics
| Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 1.47 | 1.61 | 2.57 | 1.01 | 2.39 |
| Total Income From Operations (Cr.) | 1.47 | 1.61 | 2.57 | 1.01 | 2.39 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | -43.94 | -39.11 | -49.63 | -28.02 | -27.51 |
| P/L Before Exceptional Items & Tax (Cr.) | -43.94 | -39.12 | -49.64 | -28.04 | -27.54 |
| P/L After Tax from Ordinary Activities (Cr.) | -43.94 | -39.12 | -49.64 | -28.04 | -26.54 |
| Net Profit/Loss For the Period (Cr.) | -43.94 | -39.12 | -49.64 | -28.04 | -26.54 |
| Basic EPS | -2.02 | -1.79 | -2.27 | -1.29 | -1.22 |
FAQs
Suven Life Sciences Ltd. announced its quarterly results for Q4 FY2025 on May 13, 2025.
In Q4 FY2025, Suven Life Sciences Ltd. are as follows:
Revenue: ₹2.69 crore
Net Profit: ₹-43.94 crore.
For Q4 FY2025, Suven Life Sciences Ltd. posted ₹2.69 crore in revenue and ₹-43.94 crore in net profit.
Past quarterly results for Suven Life Sciences Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.